BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 824133)

  • 1. Early detection of potentially lethal events in T cell-mediated cytolysis.
    MacDonald HR
    Eur J Immunol; 1975 Apr; 5(4):251-4. PubMed ID: 824133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
    Hiserodt JC
    J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of cytotoxic T lymphocytes in vitro. VI. Effect of cell density on response in mixed leukocyte cultures.
    Fitch FW; Engers HD; MacDonald HR; Cerottini JC; Brunner KT
    J Immunol; 1975 Dec; 115(6):1688-94. PubMed ID: 127012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Apr; 5(4):227-33. PubMed ID: 185057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate.
    Grimm EA; Thoma JA; Bonavida B
    J Immunol; 1979 Dec; 123(6):2870-7. PubMed ID: 315433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of delayed addition of 2-mercaptoethanol on the generation of mouse cytotoxic T lymphocytes in mixed leukocyte cultures.
    Engers HD; MacDonald HR; Cerottini JC; Brunner KT
    Eur J Immunol; 1975 Mar; 5(3):223-5. PubMed ID: 135683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mechanism of lymphocyte-mediated cytolysis. VII. Two stages in the T cell-mediated lytic cycle with distinct cation requirements.
    Plaut M; Bubbers JE; Henney CS
    J Immunol; 1976 Jan; 116(1):150-5. PubMed ID: 812913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and nonspecific antitumor immunity. I. Description of an in vitro assay based on inhibition of DNA synthesis in tumor cells.
    Williams RM; Germain RN; Benacerraf B
    J Natl Cancer Inst; 1975 Mar; 54(3):697-708. PubMed ID: 1091740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lethal hit stage of mouse T and non-T cell-mediated cytolysis: differences in cation requirements and characterization of an analytical "cation pulse" method.
    Golstein P; Smith ET
    Eur J Immunol; 1976 Jan; 6(1):31-7. PubMed ID: 823034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The requirements for triggering of lysis by cytolytic T lymphocyte clones. II. Cyclosporin A inhibits TCR-mediated exocytosis by only selectively inhibits TCR-mediated lytic activity by cloned CTL.
    Lancki DW; Kaper BP; Fitch FW
    J Immunol; 1989 Jan; 142(2):416-24. PubMed ID: 2492047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of T cell-mediated cytolysis by 2-deoxy-D-glucose (2-DG): differential effect of 2-DG on effector cells isolated early or late after alloantigenic stimulation in vitro.
    MacDonald HR; Cerottini JC
    J Immunol; 1979 Mar; 122(3):1067-72. PubMed ID: 156212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limited specific T-cell mediated cytolysis in the absence of extracellular Ca2+.
    MacLennan IC; Gotch FM; Golstein P
    Immunology; 1980 Jan; 39(1):109-17. PubMed ID: 6769782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-mediated immunity in lumphocytic choriomeningitis. I. The specificity of the cytotoxic T lymphocytes.
    Pfizenmaier K; Trostmann H; Röllinghoff M; Wagner H
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(3):224-36. PubMed ID: 60840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of phorbol ester-mediated reduction of cloned T lymphocyte cytolysis by interleukin 2.
    Orosz CG; Scott JW; Gillis S; Finke JH
    J Immunol; 1985 Jan; 134(1):324-9. PubMed ID: 3871104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micromethods for induction and assay of mouse mixed lymphocyte reactions and cytotoxicity.
    Simpson E; Gordon R; Taylor M; Mertin J; Chandler P
    Eur J Immunol; 1976 Jul; 5(7):451-5. PubMed ID: 135687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-mediated immunity to antigens associated with murine sarcoma virus-induced tumors: augmentation of cytolytic T lymphocyte activity by successive specific and nonspecific stimulation in vitro.
    Ryser JE; Cerottini JC; Brunner KT
    Eur J Immunol; 1979 Mar; 9(3):179-84. PubMed ID: 221224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitogenic activity of staphylococcal enterotoxin B (SEB): a monovalent T cell mitogen that stimulates cytolytic T lymphocytes but cannot mediate their lytic interaction.
    Zehavi-Willner T; Berke G
    J Immunol; 1986 Oct; 137(8):2682-7. PubMed ID: 3489771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of effector lymphocytes associated with immunity to murine sarcoma virus (MSV) induced tumors. I. Physical properties of cytolytic T lymphocytes generated in vitro and of their immediate progenitors.
    Plata R; MacDonald HR; Engers HD
    J Immunol; 1976 Jul; 117(1):52-8. PubMed ID: 180182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocyte-mediated suppression of myeloma function in vitro. I. Suppression by allogeneically activated T lymphocytes.
    Abbas AK
    J Immunol; 1979 Nov; 123(5):2011-8. PubMed ID: 114584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.